A new study published in Cell Press reveals critical insights into the role of gamma-delta T cells across 33 cancer types, ...

A new study reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer treatment.

A new report from the American Cancer Society says deaths from the disease have fallen nearly 45% compared to 35 years ago. However, new cases continue to rise.

Poster presentation details: Title: Tumor-activated immune cell engagers designed to drive synthetic immunity against cancer demonstrated protease-dependent activation and robust anti-tumor activity ...

A copy of the presentation materials can be accessed on the “Publication” section of the Company’s website at www.bioatla.com once the presentation has concluded. About BioAtla®, Inc.

Presentation Title: Development of a Surface Engineered Lentiviral Vector for In Vivo Generation of CD22-Directed CAR T Cells Presenting Author: Jeffrey Teoh, Ph.D. Poster Number: 1145 Presentation ...

Rose-Anna Hoey never imagined that she would be given a cancer diagnosis, as a leading distance runner with no genetic ...

Immunotherapy biologics represent a transformative approach in treating cancer and infections by using biological molecules to strengthen the immune system’s response. Biologics such as monoclonal ...

A phase 2/3 non-inferiority study compared de-escalation strategies to standard chemoradiation in patients with human ...

Elicera Therapeutics describes how CAR T cells armed with neutrophil-activatingprotein can improve cancer therapy by inducing ...

A new form of cancer treatment for melanoma patients has been approved by the FDA, after a clinical trial in St. Louis showed ...

A new study has demonstrated a new, non-invasive imaging technique can accurately detect clear-cell renal cell carcinoma, the most common form of kidney cancer.